BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4338441)

  • 1. Effect of probenecid on levels of cyclic AMP in human cerebrospinal fluid.
    Cramer H; Ng LK; Chase TN
    J Neurochem; 1972 Jun; 19(6):1601-2. PubMed ID: 4338441
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.
    Cramer H; Ng LK; Chase TN
    Arch Neurol; 1973 Sep; 29(3):197-9. PubMed ID: 4360419
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebrospinal fluid homovanillic acid in paralysis agitans and spinocerebellar degeneration (author's transl)].
    Mizuno Y; Ariga T
    Rinsho Shinkeigaku; 1979 Jun; 19(6):367-71. PubMed ID: 477137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cerebrospinal fluid methoxyhydroxy-phenylene glycol in Parkinson's disease and spinocerebellar degeneration (author's transl)].
    Mizuno Y
    No To Shinkei; 1979 Mar; 31(3):309-12. PubMed ID: 444338
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of probenecid and exercise on cerebrospinal-fluid cyclic A.M.P. in affective illness.
    Cramer H; Goodwin FK; Post RM; Bunney WE
    Lancet; 1972 Jun; 1(7764):1346-7. PubMed ID: 4113445
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration.
    Araki K; Takino T; Ida S; Kuriyama K
    Acta Neurol Scand; 1986 Feb; 73(2):105-10. PubMed ID: 3705920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP in cerebrospinal fluid: accumulaiton following probenecid and biogenic amines.
    Sebens JB; Korf J
    Exp Neurol; 1975 Feb; 46(2):333-44. PubMed ID: 163744
    [No Abstract]   [Full Text] [Related]  

  • 8. The CSF iron in patients with neurological diseases.
    Kjellin KG
    Acta Neurol Scand; 1967; 43(3):299-313. PubMed ID: 4227818
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal fluid cyclic AMP in parkinsonism [proceedings].
    Namba S; Ishimitsu H; Nakasone S
    Appl Neurophysiol; 1979; 42(5):309. PubMed ID: 229765
    [No Abstract]   [Full Text] [Related]  

  • 10. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
    Chase TN; Gordon EK; Ng LK
    J Neurochem; 1973 Sep; 21(3):581-7. PubMed ID: 4270247
    [No Abstract]   [Full Text] [Related]  

  • 11. [Probenecid-induced convulsion and cerebrospinal cyclic nucleotides in the kindling cat preparations (author's transl)].
    Akiyama T; Sato M; Otsuki S
    No To Shinkei; 1981 Nov; 33(11):1107-13. PubMed ID: 6277350
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of amphetamine and chlordiazepoxide on probenecid-induced accumulation of acidic metabolites in the cerebrospinal fluid of the dog.
    DeLuca DC; Angel C; Murphree OD
    Biol Psychiatry; 1977 Aug; 12(4):577-82. PubMed ID: 196692
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children.
    Winsberg BG; Sverd J; Castells S; Hurwic M; Perel JM
    Neuropediatrics; 1980 Aug; 11(3):250-5. PubMed ID: 6158716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP in cerebrospinal fluid of manic and depressive patients.
    Post RM; Cramer H; Goodwin FK
    Psychol Med; 1977 Nov; 7(4):599-605. PubMed ID: 201957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotides in cerebrospinal fluid of drug-free Parkinson patients.
    Covicković-Sternić N; Kostić VS; Djuricić BM; Bumbasirević-Beslać L; Nikolić M; Mrsulja BB
    Eur Neurol; 1987; 27(1):24-8. PubMed ID: 3040416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 18. Probenecid-induced accumulation of cyclic nucleotides, 5-hydroxyindoleacetic acid, and homovanillic acid in cisternal spinal fluid of genetically nervous dogs.
    Angel C; Deluca DC; Murphree OD
    Biol Psychiatry; 1976 Dec; 11(6):743-53. PubMed ID: 187258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
    Olsson R; Roos BE
    Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonergic mechanisms and extrapyramidal function in man.
    Chase TN
    Adv Neurol; 1974; 5():31-9. PubMed ID: 4280243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.